Deferasirox Tablet, For Suspension
Product Images NDC 62756-568

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 62756-568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-deferasirox-chemical-structure (Spl Deferasirox Chemical Structure)

Chemical structure of deferasirox, depicting its molecular framework including aromatic rings, hydroxyl groups, and nitrogen atoms in a triazole ring.*

FDA Label Image

Spl-deferasirox-figure-1 (Spl Deferasirox Figure 1)

A bar chart showing the change in liver iron content and serum ferritin levels at different doses of deferasirox tablets (5, 10, 20, and 30 mg/kg/day). Liver iron content is shown with open bars, serum ferritin with solid bars, with dose on the x-axis and changes measured on two y-axes: mg Fe/g dry weight for liver iron content and mcg/L for serum ferritin.*

FDA Label Image

Spl-deferasirox-label-125mg (Spl Deferasirox Label 125mg)

Deferasirox Tablets for Oral Suspension 125 mg label. The label states to not chew or swallow whole and instructs that tablets must be dispersed in water, orange, or apple juice prior to ingestion. It includes pharmacist instructions to dispense with a medication guide and indicates a quantity of 30 tablets. The label shows the NDC 62756-568-83 and the Sun Pharmaceutical Industries, Inc. logo.*

FDA Label Image

Spl-deferasirox-label-250mg (Spl Deferasirox Label 250mg)

Deferasirox Tablets for Oral Suspension 250 mg label from Sun Pharmaceutical Industries, Inc. The label states the dosage strength, handling instructions to disperse tablets before ingestion, storage conditions, and packaging of 30 tablets per bottle. It includes the NDC 62756-569-83 and manufacturing details from Sun Pharmaceutical Industries Ltd., India.*

FDA Label Image

Spl-deferasirox-label-500mg (Spl Deferasirox Label 500mg)

Label for Deferasirox Tablets for Oral Suspension, 500 mg strength. The label states that each uncoated tablet contains 500 mg deferasirox and provides storage instructions and dosage guidance. Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ, and manufactured by Sun Pharmaceutical Industries Ltd., India. The package contains 30 tablets for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.